ECKERT & ZIEGLER SE (EUZ.DE) Stock Price & Overview

FRA:EUZ • DE0005659700

14.75 EUR
-0.1 (-0.67%)
Last: Mar 13, 2026, 07:00 PM

The current stock price of EUZ.DE is 14.75 EUR. Today EUZ.DE is down by -0.67%. In the past month the price decreased by -1.14%. In the past year, price decreased by -48.06%.

EUZ.DE Key Statistics

52-Week Range14.25 - 34.875
Current EUZ.DE stock price positioned within its 52-week range.
1-Month Range14.5 - 15.51
Current EUZ.DE stock price positioned within its 1-month range.
Market Cap
936.92M
P/E
22.69
Fwd P/E
17.54
EPS (TTM)
0.65
Dividend Yield
1.11%

EUZ.DE Stock Performance

Today
-0.67%
1 Week
-2.31%
1 Month
-1.14%
3 Months
-1.73%
Longer-term
6 Months -13.86%
1 Year -48.06%
2 Years -21.08%
3 Years -28.83%
5 Years -56.53%
10 Years +51.07%

EUZ.DE Stock Chart

ECKERT & ZIEGLER SE / EUZ Daily stock chart

EUZ.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to EUZ.DE. When comparing the yearly performance of all stocks, EUZ.DE is a bad performer in the overall market: 92.39% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
EUZ.DE Full Technical Analysis Report

EUZ.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. EUZ.DE gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EUZ.DE Full Fundamental Analysis Report

EUZ.DE Earnings

Next Earnings DateMar 26, 2026
Last Earnings DateNov 13, 2025
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
EUZ.DE Earnings History

EUZ.DE Forecast & Estimates

8 analysts have analysed EUZ.DE and the average price target is 22.06 EUR. This implies a price increase of 49.54% is expected in the next year compared to the current price of 14.75.

For the next year, analysts expect an EPS growth of 52.72% and a revenue growth 7.52% for EUZ.DE


Analysts
Analysts80
Price Target22.06 (49.56%)
EPS Next Y52.72%
Revenue Next Year7.52%
EUZ.DE Forecast & Estimates

EUZ.DE Groups

Sector & Classification

Index Membership

EUZ.DE Financial Highlights

Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 43.67% compared to the year before.


Income Statements
Revenue(TTM)304.47M
Net Income(TTM)39.75M
Industry RankSector Rank
PM (TTM) 13.06%
ROA 8.79%
ROE 17.17%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%68.5%
Sales Q2Q%7.42%
EPS 1Y (TTM)43.67%
Revenue 1Y (TTM)9.64%
EUZ.DE financials

EUZ.DE Ownership

Ownership
Inst Owners29.07%
Shares63.52M
Float42.78M
Ins Owners0.23%
Short Float %N/A
Short RatioN/A
EUZ.DE Ownership

EUZ.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC14.3997.986B
SHL SIEMENS HEALTHINEERS AG14.8644.026B
PHI1 KONINKLIJKE PHILIPS NV15.9623.794B
PHIA KONINKLIJKE PHILIPS NV15.9623.707B
BIM BIOMERIEUX19.4911.167B
DIA DIASORIN SPA15.633.624B
OBCK OTTOBOCK SE & CO KGAA17.773.423B
AFX CARL ZEISS MEDITEC AG - BR11.52.111B
DRW3 DRAEGERWERK AG - PREF10.891.601B
DRW8 DRAEGERWERK AG8.671.287B
ELN EL.EN. SPA20.391.008B
GVS GVS SPA12.15669.697M

About EUZ.DE

Company Profile

EUZ logo image Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Company Info

IPO: 1999-05-25

ECKERT & ZIEGLER SE

Robert-Roessle-Str.10

Berlin BERLIN DE

Employees: 1085

EUZ Company Website

EUZ Investor Relations

Phone: 49309410840

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What does EUZ do?

Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.


Can you provide the latest stock price for ECKERT & ZIEGLER SE?

The current stock price of EUZ.DE is 14.75 EUR. The price decreased by -0.67% in the last trading session.


What is the dividend status of ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 1.11%. The yearly dividend amount is currently 0.02.


How is the ChartMill rating for ECKERT & ZIEGLER SE?

EUZ.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Which stock exchange lists EUZ stock?

EUZ.DE stock is listed on the Frankfurt Stock Exchange exchange.


Can you provide the sector and industry classification for ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.